DGIST Student Startup Questor recently achieved a significant milestone by winning the grand prize at the “2025 Research and Development Special Zone Science and Technology Specialized University Technology Startup Investment Competition.” Concurrently, LMNTIC Biotech, another promising startup, was awarded the excellence prize at the same event. This remarkable achievement underscores the innovative prowess and entrepreneurial spirit of the students at DGIST.
The Competition and Winners
The competition, jointly organized by the Research and Development Special Zone Promotion Foundation and Mirae Science and Technology Holdings, attracted participants from five prestigious science and technology specialized universities in South Korea. Among the six teams that advanced to the finals, Questor and LMNTIC Biotech from DGIST stood out by clinching the top honors.
Questor’s Technological Innovation
Questor, led by CEO Lee Jungwoo, impressed the judges with its cutting-edge “Motiglove” technology, a high-precision hand tracking interface designed for robotics foundation model training. This glove-type device, powered by the proprietary VIST technology, not only won the CES 2025 Innovation Award but also holds immense potential across diverse sectors such as robotics, vocational education, healthcare, military, and manufacturing. CEO Lee Jungwoo’s vision of establishing the company as a global leader in hand data and software highlights their commitment to excellence in the age of physical AI.
LMNTIC Biotech’s Breakthrough
On the other hand, LMNTIC Biotech, under the leadership of CEO Ryu Donghwan, showcased its groundbreaking “One-Step Ultra-Pure CTC Liquid Biopsy Platform.” Leveraging innovative technology developed by Professor Kim Chulki from the Department of Chemical Physics, the platform enables the isolation of circulating tumor cells (CTCs) from blood with over 90% purity in a single step using micro-magnetic electrophoresis. This revolutionary approach is poised to revolutionize personalized treatment strategies by overcoming the limitations of traditional pathology tests.
Industry Recognition and Future Prospects
The accolades garnered by Questor and LMNTIC Biotech underscore the unique technological capabilities and growth potential of DGIST student entrepreneurs. Koo Jaehyung, Director of the DGIST Office of Research and Industry Cooperation, emphasized the institution’s commitment to supporting and nurturing such innovative technologies to drive future startups and investments. The comprehensive growth support program offered to the winning startups, including validation of technology and business models, expert mentoring, and investment connections, paves the way for their successful entry into the global market.
Investment Opportunities and Collaboration
The winning companies not only received cash prizes and recognition but also gained access to investment opportunities from Mirae Science and Technology Holdings. While the grand prize and first prize winners are eligible for direct investments of up to 1 billion won, the excellence award recipients will benefit from follow-up investment reviews and support for global expansion. These opportunities not only validate the potential of the startups but also pave the way for collaboration with pharmaceutical companies to accelerate research and development in the biotech sector.
Key Takeaways
- The success of Questor and LMNTIC Biotech highlights the innovative potential of DGIST student entrepreneurs in the biotech industry.
- The competition serves as a platform to showcase groundbreaking technologies and attract investment for startups in deep-tech sectors.
- The support and recognition provided to winning startups underscore the commitment of institutions to fostering technological innovation and entrepreneurship.
- The collaboration opportunities arising from the competition pave the way for future advancements in personalized medicine and biotech research.
- The accolades received by Questor and LMNTIC Biotech underscore the importance of investing in cutting-edge technologies with the potential to transform healthcare and other industries.
- The competition not only rewards excellence but also provides a launching pad for startups to gain visibility, funding, and industry connections.
In conclusion, the triumph of Questor and the excellence of LMNTIC Biotech at the prestigious competition exemplify the transformative potential of innovative technologies in the biotech landscape. As these startups continue to push boundaries and redefine industry standards, they not only inspire the next generation of entrepreneurs but also pave the way for groundbreaking advancements in healthcare, technology, and beyond.
Tags: biotech, sports
Read more on asiae.co.kr